Skip to main content
. Author manuscript; available in PMC: 2014 Aug 17.
Published in final edited form as: Cancer Biol Ther. 2007 Jul 24;6(10):1632–1637. doi: 10.4161/cbt.6.10.4790

Figure 2.

Figure 2

Anti-tumor efficacy of C-1748 and C-1860, C-1872, C-1873 in human TSU xenografts in nude mice. Animals were randomized into treatment and control groups (six mice/group). Treatment was started when tumors were palpable (40 mm3) and continued once a week for six weeks. Tumor growth was measured using Vernier calipers and tumor volume calculated.